Lv4
490 积分 2024-11-28 加入
Efficacy and adverse effects of lower doses of ketorolac; a systematic review and meta-analysis
6天前
已完结
Safety and efficacy of continuous subcutaneous levodopa–carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial
11天前
已完结
The Safety and Efficacy of Subcutaneous Forms of Levodopa/Carbidopa (ND0612 and Foslevodopa/Foscarbidopa) on Parkinson’s Disease Patients: Systematic Review and Meta Analysis (P11-5.030)
11天前
已关闭
Efficacy and Safety of Tavapadon, an Orally Administered, Once-daily, Selective D1/D5 Partial Dopamine Agonist, Adjunctive to Levodopa for Treatment of Parkinson’s Disease with Motor Fluctuations (S37.003)
11天前
已关闭
Exploring the Pharmaceutical Significance and Analytical Landscape of Ropinirole: An In-Depth Review of an Indole-Based Dopaminergic Therapeutic Agent
11天前
已完结
Targeting cancer stem cells: Dual-drug delivery systems and their role in cancer therapy
11天前
已完结
Poly (lactic-co-glycolic acid)-based microneedles for drug delivery across different biological barriers
11天前
已关闭
Efficacy and Safety of Novel Continuous Subcutaneous Levodopa Infusion Therapies ND0612 and ABBV-951 for Parkinson’s Disease: A Systematic Review
11天前
已完结
Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trial
11天前
已完结
A Novel Levodopa/Carbidopa Prodrug (ABBV-951) 24-Hour Continuous Subcutaneous Infusion Treatment for Parkinson’s Disease (P3.8-037)
11天前
已关闭
皖公网安备34019202002308
